Brainstorm Cell Therapeutics Inc Sustainability Reports

Brainstorm Cell Therapeutics Inc. is a biotechnology company focused on the development and commercialization of innovative autologous cellular therapies for highly debilitating neurodegenerative diseases, such as Amyotrophic Lateral Sclerosis (ALS) and Progressive Multiple Sclerosis (MS).

Sector: Manufacturing

Country: United States

Exchange: OTC Markets

LEI: 529900ULKWCLO3ZHXL41

6 reports from 2011 to 2023

• Brainstorm Cell Therapeutics Inc 2023 Annual Report on Form 10-K
• Brainstorm Cell Therapeutics Inc 2021 Annual Report on Form 10-K
• Brainstorm Cell Therapeutics Inc 2020 Annual Report on Form 10-K
• Brainstorm Cell Therapeutics Inc 2017 Annual Report on Form 10-K
• Brainstorm Cell Therapeutics Inc 2012 Annual Report on Form 10-K